Subscribe to RSS - ResMed

ResMed

In brief: CMS delays F2F rule again, Golden endorses Reverie

 - 
09/13/2013

BALTIMORE – CMS had no choice but to delay—for the second time—enforcement of its face-to-face rule until sometime in 2014, say industry stakeholders. “We just haven’t seen any further education,*” said Kim Brummett, senior director of regulatory affairs for AAHomecare.

Compliant patient, efficient provider

 - 
09/11/2013

In a move they believe will make patients more compliant and HME providers more efficient, two of the largest manufacturers of CPAP devices have rolled out mobile and web-based sleep therapy tools.

ResMed director sells $1.2m in company stock

 - 
09/10/2013

SAN DIEGO – Peter Farrell, ResMed director, sold 25,000 shares of stock on Sept. 5.

Patients in place for ResMed sleep apnea study

 - 
09/03/2013

AMSTERDAM – More than 1,300 patients are signed up for a large study examining the outcomes of heart-failure patients using ResMed’s PaceWave to treat central sleep apnea. ResMed announced Sept.

Manufacturers reassess terms

 - 
08/30/2013

YARMOUTH, Maine – With three high-profile HME providers now moving through the bankruptcy process, should it come as a surprise that manufacturers are trying to protect themselves by tightening their payment terms?

Sleep vendors continue legal wrangle

 - 
08/21/2013

SAN DIEGO – ResMed has announced that the International Trade Commission (ITC) has agreed to investigate BMC Medical, a Chinese medical device manufacturer, and its U.S.-based distributors, 3B Medical and 3B Products, for patent infringement.

Pricing concerns cloud ResMed’s solid earnings

 - 
08/06/2013

SAN DIEGO – Whether or not ResMed is giving steep discounts to cash-strapped HME providers was the hot topic during an Aug. 1 call to discuss the company’s recent earnings.

Pricing concerns cloud ResMed’s solid earnings

 - 
08/09/2013

SAN DIEGO – Whether or not ResMed is giving steep discounts to cash-strapped HME providers was the hot topic during an Aug. 1 call to discuss the company’s recent earnings.

Record quarter, year for ResMed

 - 
08/02/2013

SAN DIEGO – ResMed this week reported revenue of $414.6 million for the quarter ended June 30, 2013, an 11% increase over the same quarter last year. GAAP net income for the quarter was $73 million or $.50 cents per share.

Pages